首页> 外文会议>IEEE Nuclear Science Symposium and Medical Imaging Conference >Effects of high photon fluence rate from therapeutic radionuclides on preclinical and clinical PET systems
【24h】

Effects of high photon fluence rate from therapeutic radionuclides on preclinical and clinical PET systems

机译:治疗性放射性核素的高光子注量速率对临床前和临床PET系统的影响

获取原文

摘要

Tumor response in radionuclide therapy can be monitored with PET/CT and/or PET/MR. A high background photon fluence from a therapy radionuclide may influence both image quality and quantification, when imaging is performed intra-therapeutically, i.e. with high activity of the therapeutic radionuclide present. Here, count losses and image distortion have been investigated for preclinical and clinical PET systems with different detector designs. The effect on the spatial resolution was studied with a point source of Na in a background of Tc, where Tc emulated the photon emission from a therapeutic radionuclide. An in-house made mouse phantom with silicon tubes filled with Tc with a centrally placed Na point source was used. For the clinical systems, a 70 cm long NEMA PET Scatter Phantom was used, with a Na point source placed at the center whereas the off-center silicon tube was filled with Tc. In addition, image quality was also evaluated in the presence of different levels of Tc with a F-filled NEMA image quality phantom on the preclinical systems and a F-filled Jaszczak phantom on the clinical system. Preclinical PET systems with different detector geometries showed that the addition of Tc affected the count rate capability considerably, especially those with a low number of read-out channels. The coincidence rate for was significantly reduced when high activities of Tc were present. The clinical PET system also showed an effect of reduced coincidence rate with increased photon fluence rate. At high Tc activities, the spatial resolution was degraded for both the preclinical and the clinical systems. The quantitative capability of PET systems used intra-therapeutically is significantly affected by the additional high photon fluence rate. The dead-time correction implemented on some of the in- estigated PET systems, was able to accurately compensate for the coincidence count losses. The reduced spatial resolution at high photon fluence rate, however, remains a potentially limiting factor.
机译:可以使用PET / CT和/或PET / MR监测放射性核素治疗中的肿瘤反应。当在治疗内(即存在治疗放射性核素的高活性)成像时,来自治疗放射性核素的高背景光子通量可能会影响图像质量和定量。在这里,已经针对具有不同检测器设计的临床前和临床PET系统研究了计数损失和图像失真。在Tc的背景下,使用Na的点源研究了空间分辨率的影响,其中Tc模拟了治疗性放射性核素的光子发射。使用内部制作的幻影鼠标,该幻影带有填充有Tc的硅管和居中放置的Na点源。对于临床系统,使用70厘米长的NEMA PET散射体模,将Na点源放置在中心,而偏心的硅管则用Tc填充。此外,还通过在临床前系统上使用F填充的NEMA图像质量幻像和在临床系统上使用F填充的Jaszczak幻象在不同水平的Tc的存在下评估图像质量。具有不同检测器几何形状的临床前PET系统显示,添加Tc会显着影响计数率功能,尤其是那些具有少量读出通道的系统。存在高Tc活性时,的符合率显着降低。临床PET系统还显示出降低符合率和增加光子注量率的效果。在高Tc活动下,临床前和临床系统的空间分辨率都会下降。额外使用的高光子注量速率显着影响了治疗内使用的PET系统的定量能力。在某些被调查的PET系统上执行的停滞时间校正能够准确补偿同时发生的计数损失。然而,在高光子注量速率下降低的空间分辨率仍然是潜在的限制因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号